Presentation The Structural Heart Disease Summit 2018 TAVR to Treat Pure Aortic Regurgitation: Published and Personal Experiences (With Case Examples) Presenter: Howard C. Herrmann, Allan Schwartz, Eberhard Grube June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A) Presenter: Francesco Maisano June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Program Update: The LOTUS Edge TAVR System: Design Characteristics, Clinical Data, and Future Vision Presenter: Axel Linke, Vinod H. Thourani, Ted Feldman June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset Presenter: Howard C. Herrmann, Allan Schwartz, Jonathan Afilalo June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders? Presenter: Howard C. Herrmann, Allan Schwartz, Suzanne V. Arnold June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study Presenter: David A. Wood June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Conductor (Illustrative Cases) Presenter: Tamim Nazif June 22, 2018
Presentation The Structural Heart Disease Summit 2018 CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS Presenter: Howard C. Herrmann, Allan Schwartz June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages Presenter: David J. Cohen June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Program Update: The SAPIEN 3 TAVR System - Design Characteristics, Clinical Data, and Future Vision Presenter: Axel Linke, Vinod H. Thourani, John G. Webb June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients Presenter: Howard C. Herrmann, Allan Schwartz, Philippe Genereux June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions Presenter: Brian R Lindman June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Conductor (Illustrative Cases) Presenter: John Forrest June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction Presenter: Howard C. Herrmann, Allan Schwartz, Nicolas M. Van Mieghem June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Double Device Harmony for Challenging Anatomy Presenter: Horst Sievert, Robert J. Sommer, David Meerkin June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Keynote Lecture #1: New AS Classification Scheme Based on Cardiac Damage - Changes After AVR Presenter: Philippe Genereux June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Program Update: The Evolut R/PRO TAVR System: Design Characteristics, Clinical Data, and Future Vision Presenter: Axel Linke, Vinod H. Thourani, Jeffrey J. Popma June 22, 2018
Presentation The Structural Heart Disease Summit 2018 A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis Presenter: Howard C. Herrmann, Allan Schwartz June 22, 2018
Presentation The Structural Heart Disease Summit 2018 A Case of Primary in Which Sequential Transcatheter Procedures May Be Appropriate Presenter: Omar Khalique June 22, 2018
Presentation The Structural Heart Disease Summit 2018 A TR Case in the Presence of a Prior Tricuspid Valve Replacement Presenter: Thomas Smith June 22, 2018